Literature DB >> 9093351

Exercise testing and prognosis in adult cystic fibrosis.

A J Moorcroft1, M E Dodd, A K Webb.   

Abstract

BACKGROUND: The assessment of prognosis is an important issue in cystic fibrosis. The prognostic value of exercise testing in comparison with other predictors of mortality was examined.
METHODS: Ninety two adult patients with cystic fibrosis performed progressive maximal exercise tests and outcome was assessed at five years. The results of exercise testing were examined along with spirometric values, age, sex, body mass index (BMI), and sputum culture.
RESULTS: Twenty two subjects died during the five year follow up period and 67 survived. Five subjects received a lung transplant and were excluded from the analysis. There were significant differences between those who survived and those who died: mean (SE) forced expiratory volume in one second (FEV1) 68.9 (2.7) versus 39.7 (3.5)% predicted, BMI 19.0 (0.3) versus 17.1 (0.4) kg/m2, peak oxygen uptake (VO2 peak) 66.6 (2.2) versus (53.7) (3.7)% predicted, peak work rate (Wpeak) 89.4 (3.8) versus 71.2 (5.5)% predicted, peak minute ventilation (VEpeak) 51.3 (2.0) versus 43.3 (3.1) 1/min, and ventilatory equivalent for oxygen (VE/VO2) 32.4 (0.6) versus 38.7 (1.7). Age, sex, oxygen saturation and Burkholderia cepacia colonisation were not found to be significant predictors of mortality. When significant independent factors were entered into a multivariate logistic regression model only FEV1 was found to be a significant correlate of mortality. A cutoff for FEV1 of 55% predicted gave the best combination of specificity and sensitivity with 54% of those below this value dying within five years and 96% of those above it surviving.
CONCLUSIONS: The results of maximal exercise testing are correlated with survival but they are not better than the FEV1 as prognostic indicators.

Entities:  

Mesh:

Year:  1997        PMID: 9093351      PMCID: PMC1758504          DOI: 10.1136/thx.52.3.291

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Multiple factors limit exercise capacity in cystic fibrosis.

Authors:  J E Marcotte; R K Grisdale; H Levison; A L Coates; G J Canny
Journal:  Pediatr Pulmonol       Date:  1986 Sep-Oct

2.  Pulmonary function and response to exercise in cystic fibrosis.

Authors:  S Godfrey; M Mearns
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

3.  Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Authors:  R J Knudson; M D Lebowitz; C J Holberg; B Burrows
Journal:  Am Rev Respir Dis       Date:  1983-06

4.  Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation.

Authors:  L Sharples; T Hathaway; C Dennis; N Caine; T Higenbottam; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1993 Jul-Aug       Impact factor: 10.247

5.  Prediction of mortality in patients with cystic fibrosis.

Authors:  E Kerem; J Reisman; M Corey; G J Canny; H Levison
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245

6.  Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients.

Authors:  R Zinman; M Corey; A L Coates; G J Canny; J Connolly; H Levison; P H Beaudry
Journal:  J Pediatr       Date:  1989-03       Impact factor: 4.406

7.  The prognostic value of exercise testing in patients with cystic fibrosis.

Authors:  P A Nixon; D M Orenstein; S F Kelsey; C F Doershuk
Journal:  N Engl J Med       Date:  1992-12-17       Impact factor: 91.245

8.  Cystic fibrosis in adolescents and adults.

Authors:  A R Penketh; A Wise; M B Mearns; M E Hodson; J C Batten
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

9.  Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.

Authors:  L O Lewin; P J Byard; P B Davis
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

10.  Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis.

Authors:  N N Huang; D V Schidlow; T H Szatrowski; J Palmer; L R Laraya-Cuasay; W Yeung; K Hardy; L Quitell; S Fiel
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

View more
  23 in total

Review 1.  The heart in cystic fibrosis.

Authors:  Rowland J Bright-Thomas; A Kevin Webb
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Exercise and sport in cystic fibrosis: benefits and risks.

Authors:  A K Webb; M E Dodd
Journal:  Br J Sports Med       Date:  1999-04       Impact factor: 13.800

3.  Peak oxygen uptake and mortality in children with cystic fibrosis.

Authors:  P Pianosi; J Leblanc; A Almudevar
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

4.  Exercise testing in cystic fibrosis: why (and how)?

Authors:  D S Urquhart
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

5.  Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis?

Authors:  S M Javadpour; H Selvadurai; D L Wilkes; J Schneiderman-Walker; A L Coates
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

6.  Evidence of microvascular dysfunction in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Jeffrey Thomas; Nichole Seigler; Reva Crandall; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-15       Impact factor: 4.733

7.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13

8.  Exercise training in children and adolescents with cystic fibrosis: theory into practice.

Authors:  Craig A Williams; Christian Benden; Daniel Stevens; Thomas Radtke
Journal:  Int J Pediatr       Date:  2010-09-19

Review 9.  Growth hormone and exercise tolerance in patients with cystic fibrosis.

Authors:  Matthias Hütler; Ralph Beneke
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  The relationship between cardiac hemodynamics and exercise tolerance in cystic fibrosis.

Authors:  Erik H Van Iterson; Courtney M Wheatley; Sarah E Baker; Wayne J Morgan; Eric M Snyder
Journal:  Heart Lung       Date:  2016-04-01       Impact factor: 2.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.